-5%
Mirogabalin, the active ingredient in Sindola, belongs to the class of gamma amino acids and their derivatives. It works by selectively binding to the α2δ subunits of voltage-gated calcium channels (VGCCs), reducing calcium influx and neurotransmitter release in presynaptic neurons. This results in decreased hyper-excitability of neurons in the central nervous system (CNS).
Absorption and Distribution:
- Mirogabalin is rapidly absorbed, with a median time to peak plasma concentration of 0.5 to 1.5 hours.
- It has low plasma protein binding (~25%) and a volume of distribution ranging from 64-88L after single or repeated doses.
Metabolism and Excretion:
- Most of the drug (61-72%) is excreted unchanged through the kidneys, with a smaller portion (13-20%) metabolized by liver enzymes (specifically uridine 5′-diphosphate-glucuronosyltransferase isoforms).
- The elimination half-life is approximately 2-4.9 hours, with 99% excretion via the kidneys and only 1% through feces.
Sindola tablet is prescribed for the treatment of the following conditions:
- Neuropathic pain
- Diabetic peripheral neuropathic pain (DPNP)
- Postherpetic neuralgia (PHN)
- Peripheral neuropathic pain (PNP)
Take this medication only as directed by a registered physician.
